• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Ab De Novo Sequencing Market, Global Outlook and Forecast 2024-2030

Ab De Novo Sequencing Market, Global Outlook and Forecast 2024-2030

  • Category:Energy and Natural Resources
  • Published on : 27 July 2024
  • Pages :64
  • Formats:
  • Report Code:24MRES-7976788
Click for best price

Best Price: $2600

The global Ab De Novo Sequencing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ab De Novo Sequencing include Nanjing Mingyan Biotechnology Co., Ltd., Suzhou Jinweizhi Biotechnology Co., Ltd., Beijing Baitai Parker Biotechnology Co., Ltd., Biocompare, Abveris, Rapid Novor, GenScript, Absolute Antibody and Curia Global, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Ab De Novo Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ab De Novo Sequencing. This report contains market size and forecasts of Ab De Novo Sequencing in global, including the following market information:
Global Ab De Novo Sequencing Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Ab De Novo Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ab De Novo Sequencing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Ab De Novo Sequencing Market Segment Percentages, by Type, 2023 (%)
Monoclonal Antibodies
Polyclonal Antibodies
Global Ab De Novo Sequencing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Ab De Novo Sequencing Market Segment Percentages, by Application, 2023 (%)
Academic and Research Institutions
Pharmaceutical and Biotech Companies
Diagnostic and Clinical Laboratories
Other
Global Ab De Novo Sequencing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Ab De Novo Sequencing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ab De Novo Sequencing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Ab De Novo Sequencing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nanjing Mingyan Biotechnology Co., Ltd.
Suzhou Jinweizhi Biotechnology Co., Ltd.
Beijing Baitai Parker Biotechnology Co., Ltd.
Biocompare
Abveris
Rapid Novor
GenScript
Absolute Antibody
Curia Global
ProteoGenix
CiteAb
BIOZOL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ab De Novo Sequencing, market overview.
Chapter 2: Global Ab De Novo Sequencing market size in revenue.
Chapter 3: Detailed analysis of Ab De Novo Sequencing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ab De Novo Sequencing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Ab De Novo Sequencing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ab De Novo Sequencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ab De Novo Sequencing Overall Market Size
2.1 Global Ab De Novo Sequencing Market Size: 2023 VS 2030
2.2 Global Ab De Novo Sequencing Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ab De Novo Sequencing Players in Global Market
3.2 Top Global Ab De Novo Sequencing Companies Ranked by Revenue
3.3 Global Ab De Novo Sequencing Revenue by Companies
3.4 Top 3 and Top 5 Ab De Novo Sequencing Companies in Global Market, by Revenue in 2023
3.5 Global Companies Ab De Novo Sequencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ab De Novo Sequencing Players in Global Market
3.6.1 List of Global Tier 1 Ab De Novo Sequencing Companies
3.6.2 List of Global Tier 2 and Tier 3 Ab De Novo Sequencing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ab De Novo Sequencing Market Size Markets, 2023 & 2030
4.1.2 Monoclonal Antibodies
4.1.3 Polyclonal Antibodies
4.2 By Type - Global Ab De Novo Sequencing Revenue & Forecasts
4.2.1 By Type - Global Ab De Novo Sequencing Revenue, 2019-2024
4.2.2 By Type - Global Ab De Novo Sequencing Revenue, 2025-2030
4.2.3 By Type - Global Ab De Novo Sequencing Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ab De Novo Sequencing Market Size, 2023 & 2030
5.1.2 Academic and Research Institutions
5.1.3 Pharmaceutical and Biotech Companies
5.1.4 Diagnostic and Clinical Laboratories
5.1.5 Other
5.2 By Application - Global Ab De Novo Sequencing Revenue & Forecasts
5.2.1 By Application - Global Ab De Novo Sequencing Revenue, 2019-2024
5.2.2 By Application - Global Ab De Novo Sequencing Revenue, 2025-2030
5.2.3 By Application - Global Ab De Novo Sequencing Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Ab De Novo Sequencing Market Size, 2023 & 2030
6.2 By Region - Global Ab De Novo Sequencing Revenue & Forecasts
6.2.1 By Region - Global Ab De Novo Sequencing Revenue, 2019-2024
6.2.2 By Region - Global Ab De Novo Sequencing Revenue, 2025-2030
6.2.3 By Region - Global Ab De Novo Sequencing Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Ab De Novo Sequencing Revenue, 2019-2030
6.3.2 US Ab De Novo Sequencing Market Size, 2019-2030
6.3.3 Canada Ab De Novo Sequencing Market Size, 2019-2030
6.3.4 Mexico Ab De Novo Sequencing Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Ab De Novo Sequencing Revenue, 2019-2030
6.4.2 Germany Ab De Novo Sequencing Market Size, 2019-2030
6.4.3 France Ab De Novo Sequencing Market Size, 2019-2030
6.4.4 U.K. Ab De Novo Sequencing Market Size, 2019-2030
6.4.5 Italy Ab De Novo Sequencing Market Size, 2019-2030
6.4.6 Russia Ab De Novo Sequencing Market Size, 2019-2030
6.4.7 Nordic Countries Ab De Novo Sequencing Market Size, 2019-2030
6.4.8 Benelux Ab De Novo Sequencing Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Ab De Novo Sequencing Revenue, 2019-2030
6.5.2 China Ab De Novo Sequencing Market Size, 2019-2030
6.5.3 Japan Ab De Novo Sequencing Market Size, 2019-2030
6.5.4 South Korea Ab De Novo Sequencing Market Size, 2019-2030
6.5.5 Southeast Asia Ab De Novo Sequencing Market Size, 2019-2030
6.5.6 India Ab De Novo Sequencing Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Ab De Novo Sequencing Revenue, 2019-2030
6.6.2 Brazil Ab De Novo Sequencing Market Size, 2019-2030
6.6.3 Argentina Ab De Novo Sequencing Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ab De Novo Sequencing Revenue, 2019-2030
6.7.2 Turkey Ab De Novo Sequencing Market Size, 2019-2030
6.7.3 Israel Ab De Novo Sequencing Market Size, 2019-2030
6.7.4 Saudi Arabia Ab De Novo Sequencing Market Size, 2019-2030
6.7.5 UAE Ab De Novo Sequencing Market Size, 2019-2030
7 Ab De Novo Sequencing Companies Profiles
7.1 Nanjing Mingyan Biotechnology Co., Ltd.
7.1.1 Nanjing Mingyan Biotechnology Co., Ltd. Company Summary
7.1.2 Nanjing Mingyan Biotechnology Co., Ltd. Business Overview
7.1.3 Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Major Product Offerings
7.1.4 Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.1.5 Nanjing Mingyan Biotechnology Co., Ltd. Key News & Latest Developments
7.2 Suzhou Jinweizhi Biotechnology Co., Ltd.
7.2.1 Suzhou Jinweizhi Biotechnology Co., Ltd. Company Summary
7.2.2 Suzhou Jinweizhi Biotechnology Co., Ltd. Business Overview
7.2.3 Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Major Product Offerings
7.2.4 Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.2.5 Suzhou Jinweizhi Biotechnology Co., Ltd. Key News & Latest Developments
7.3 Beijing Baitai Parker Biotechnology Co., Ltd.
7.3.1 Beijing Baitai Parker Biotechnology Co., Ltd. Company Summary
7.3.2 Beijing Baitai Parker Biotechnology Co., Ltd. Business Overview
7.3.3 Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Major Product Offerings
7.3.4 Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.3.5 Beijing Baitai Parker Biotechnology Co., Ltd. Key News & Latest Developments
7.4 Biocompare
7.4.1 Biocompare Company Summary
7.4.2 Biocompare Business Overview
7.4.3 Biocompare Ab De Novo Sequencing Major Product Offerings
7.4.4 Biocompare Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.4.5 Biocompare Key News & Latest Developments
7.5 Abveris
7.5.1 Abveris Company Summary
7.5.2 Abveris Business Overview
7.5.3 Abveris Ab De Novo Sequencing Major Product Offerings
7.5.4 Abveris Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.5.5 Abveris Key News & Latest Developments
7.6 Rapid Novor
7.6.1 Rapid Novor Company Summary
7.6.2 Rapid Novor Business Overview
7.6.3 Rapid Novor Ab De Novo Sequencing Major Product Offerings
7.6.4 Rapid Novor Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.6.5 Rapid Novor Key News & Latest Developments
7.7 GenScript
7.7.1 GenScript Company Summary
7.7.2 GenScript Business Overview
7.7.3 GenScript Ab De Novo Sequencing Major Product Offerings
7.7.4 GenScript Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.7.5 GenScript Key News & Latest Developments
7.8 Absolute Antibody
7.8.1 Absolute Antibody Company Summary
7.8.2 Absolute Antibody Business Overview
7.8.3 Absolute Antibody Ab De Novo Sequencing Major Product Offerings
7.8.4 Absolute Antibody Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.8.5 Absolute Antibody Key News & Latest Developments
7.9 Curia Global
7.9.1 Curia Global Company Summary
7.9.2 Curia Global Business Overview
7.9.3 Curia Global Ab De Novo Sequencing Major Product Offerings
7.9.4 Curia Global Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.9.5 Curia Global Key News & Latest Developments
7.10 ProteoGenix
7.10.1 ProteoGenix Company Summary
7.10.2 ProteoGenix Business Overview
7.10.3 ProteoGenix Ab De Novo Sequencing Major Product Offerings
7.10.4 ProteoGenix Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.10.5 ProteoGenix Key News & Latest Developments
7.11 CiteAb
7.11.1 CiteAb Company Summary
7.11.2 CiteAb Business Overview
7.11.3 CiteAb Ab De Novo Sequencing Major Product Offerings
7.11.4 CiteAb Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.11.5 CiteAb Key News & Latest Developments
7.12 BIOZOL
7.12.1 BIOZOL Company Summary
7.12.2 BIOZOL Business Overview
7.12.3 BIOZOL Ab De Novo Sequencing Major Product Offerings
7.12.4 BIOZOL Ab De Novo Sequencing Revenue in Global Market (2019-2024)
7.12.5 BIOZOL Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Ab De Novo Sequencing Market Opportunities & Trends in Global Market
Table 2. Ab De Novo Sequencing Market Drivers in Global Market
Table 3. Ab De Novo Sequencing Market Restraints in Global Market
Table 4. Key Players of Ab De Novo Sequencing in Global Market
Table 5. Top Ab De Novo Sequencing Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Ab De Novo Sequencing Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Ab De Novo Sequencing Revenue Share by Companies, 2019-2024
Table 8. Global Companies Ab De Novo Sequencing Product Type
Table 9. List of Global Tier 1 Ab De Novo Sequencing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ab De Novo Sequencing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Ab De Novo Sequencing Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Ab De Novo Sequencing Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Ab De Novo Sequencing Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Ab De Novo Sequencing Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Ab De Novo Sequencing Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Ab De Novo Sequencing Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Ab De Novo Sequencing Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Ab De Novo Sequencing Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Ab De Novo Sequencing Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Ab De Novo Sequencing Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Ab De Novo Sequencing Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Ab De Novo Sequencing Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Ab De Novo Sequencing Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Ab De Novo Sequencing Revenue, (US$, Mn), 2025-2030
Table 30. Nanjing Mingyan Biotechnology Co., Ltd. Company Summary
Table 31. Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Product Offerings
Table 32. Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 33. Nanjing Mingyan Biotechnology Co., Ltd. Key News & Latest Developments
Table 34. Suzhou Jinweizhi Biotechnology Co., Ltd. Company Summary
Table 35. Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Product Offerings
Table 36. Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 37. Suzhou Jinweizhi Biotechnology Co., Ltd. Key News & Latest Developments
Table 38. Beijing Baitai Parker Biotechnology Co., Ltd. Company Summary
Table 39. Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Product Offerings
Table 40. Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 41. Beijing Baitai Parker Biotechnology Co., Ltd. Key News & Latest Developments
Table 42. Biocompare Company Summary
Table 43. Biocompare Ab De Novo Sequencing Product Offerings
Table 44. Biocompare Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 45. Biocompare Key News & Latest Developments
Table 46. Abveris Company Summary
Table 47. Abveris Ab De Novo Sequencing Product Offerings
Table 48. Abveris Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 49. Abveris Key News & Latest Developments
Table 50. Rapid Novor Company Summary
Table 51. Rapid Novor Ab De Novo Sequencing Product Offerings
Table 52. Rapid Novor Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 53. Rapid Novor Key News & Latest Developments
Table 54. GenScript Company Summary
Table 55. GenScript Ab De Novo Sequencing Product Offerings
Table 56. GenScript Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 57. GenScript Key News & Latest Developments
Table 58. Absolute Antibody Company Summary
Table 59. Absolute Antibody Ab De Novo Sequencing Product Offerings
Table 60. Absolute Antibody Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 61. Absolute Antibody Key News & Latest Developments
Table 62. Curia Global Company Summary
Table 63. Curia Global Ab De Novo Sequencing Product Offerings
Table 64. Curia Global Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 65. Curia Global Key News & Latest Developments
Table 66. ProteoGenix Company Summary
Table 67. ProteoGenix Ab De Novo Sequencing Product Offerings
Table 68. ProteoGenix Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 69. ProteoGenix Key News & Latest Developments
Table 70. CiteAb Company Summary
Table 71. CiteAb Ab De Novo Sequencing Product Offerings
Table 72. CiteAb Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 73. CiteAb Key News & Latest Developments
Table 74. BIOZOL Company Summary
Table 75. BIOZOL Ab De Novo Sequencing Product Offerings
Table 76. BIOZOL Ab De Novo Sequencing Revenue (US$, Mn) & (2019-2024)
Table 77. BIOZOL Key News & Latest Developments
List of Figures
Figure 1. Ab De Novo Sequencing Segment by Type in 2023
Figure 2. Ab De Novo Sequencing Segment by Application in 2023
Figure 3. Global Ab De Novo Sequencing Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Ab De Novo Sequencing Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Ab De Novo Sequencing Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ab De Novo Sequencing Revenue in 2023
Figure 8. By Type - Global Ab De Novo Sequencing Revenue Market Share, 2019-2030
Figure 9. By Application - Global Ab De Novo Sequencing Revenue Market Share, 2019-2030
Figure 10. By Type - Global Ab De Novo Sequencing Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Ab De Novo Sequencing Revenue Market Share, 2019-2030
Figure 12. By Application - Global Ab De Novo Sequencing Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Ab De Novo Sequencing Revenue Market Share, 2019-2030
Figure 14. By Region - Global Ab De Novo Sequencing Revenue Market Share, 2019-2030
Figure 15. By Country - North America Ab De Novo Sequencing Revenue Market Share, 2019-2030
Figure 16. US Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Ab De Novo Sequencing Revenue Market Share, 2019-2030
Figure 20. Germany Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 21. France Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Ab De Novo Sequencing Revenue Market Share, 2019-2030
Figure 28. China Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 32. India Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Ab De Novo Sequencing Revenue Market Share, 2019-2030
Figure 34. Brazil Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Ab De Novo Sequencing Revenue Market Share, 2019-2030
Figure 37. Turkey Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Ab De Novo Sequencing Revenue, (US$, Mn), 2019-2030
Figure 41. Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Biocompare Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Abveris Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Rapid Novor Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. GenScript Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Absolute Antibody Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Curia Global Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. ProteoGenix Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. CiteAb Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. BIOZOL Ab De Novo Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)

SELECT A FORMAT

USD GBP EURO YEN Single User License
USD GBP EURO YEN Multi User License
USD GBP EURO YEN Corporate User License

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount